NCT02047500 2025-05-11Phase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic CancerImmunoGenesisPhase 1 Terminated19 enrolled 6 charts
NCT01833546 2018-10-15A Japanese Phase 1 Trial of TH-302 in Subjects With Solid Tumors and Pancreatic CancerMerck KGaA, Darmstadt, GermanyPhase 1 Completed20 enrolled 35 charts
NCT03098160 2017-10-30Immunotherapy Study of Evofosfamide in Combination With IpilimumabThreshold PharmaceuticalsPhase 1 Unknown69 enrolled